Custom Digital PCR assays for oncology refer to specialized and tailored molecular biology techniques designed for the detection and quantification of specific DNA sequences associated with cancer. Digital PCR is a highly sensitive method that allows for the absolute quantification of target DNA molecules.
In the context of oncology, custom assays are developed to amplify and analyze genetic material relevant to cancer, such as mutations, gene rearrangements, or copy number variations. These assays are often designed based on the unique genetic characteristics of a particular cancer type or subtype.
Custom Digital PCR assays offer advantages such as high sensitivity and accuracy, making them valuable tools in oncology research and clinical diagnostics. They enable researchers and clinicians to identify specific genetic markers associated with cancer, monitor disease progression, and assess the effectiveness of targeted therapies. These assays contribute to the growing field of precision medicine by tailoring treatments to the individual genetic profile of each patient's cancer.